Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

US Patent 8987228 · Granted Mar 24, 2015

Estimated economic value: $1,566,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

A3 adenosine receptor ligand for use for achieving a fat loss effect2025
Method for treating fibrotic liver tissue using Cl-IB-MECA2022
Method for treating NASH accompanied by fibrosis using Cl-IB-MECA2020
Use of A3 adenosine receptor agonist in osteoarthritis treatment2019
A3 adenosine receptor ligands for use in treatment of a sexual dysfunction2017
Method for inducing hepatocyte proliferation and uses thereof2016
Method for inducing hepatocyte proliferation and uses thereof2014
A3 adenoside receptor agonists for the reduction of intraocular pressure2013
Biological marker for inflammation2013
Treatment of dry eye conditions2010
Use of an adenosine A3 receptor agonist for inhibition of viral replication2009
Method for treatment of multiple sclerosis2008